Peripheral mechanisms of intestinal dysmotility in the morphine tolerant and dependent rats

Journal of Physiology and Pharmacology

Volumn 57, Issue 1, 2006, Pages 73-82

  Banach, T ^a   Zurowski, D ^a   Gil, K ^a   Weisbrodt, N W ^b   Rosenfeld, G ^b   Thor, P J ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

c Kit antigen; Morphine dependence; Morphine tolerance; Vagal afferent activity

Indexed keywords

DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; MORPHINE; MU OPIATE RECEPTOR; OPIATE; STEM CELL FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; ASCENDING COLON; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; DUODENUM; IMAGE ANALYSIS; INTERSTITIAL CELL OF CAJAL; INTESTINAL DYSMOTILITY; INTESTINE WALL; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; MUSCLE CELL; NERVE CONDUCTION; NERVE POTENTIAL; NONHUMAN; RAT; RECEPTOR BLOCKING; VAGUS NERVE; VAGUS REFLEX;

ANIMALS; COLON; DRUG TOLERANCE; DUODENUM; GASTROINTESTINAL MOTILITY; MALE; MORPHINE; MORPHINE DEPENDENCE; NEURONS, AFFERENT; PROTO-ONCOGENE PROTEINS C-KIT; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; SOMATOSTATIN; VAGUS NERVE;

EID: 33645574102     PISSN: 08675910     EISSN: 08675910     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bates JJ, Foss JF, Murphy DB. Are peripheral opioid antagonists the solution to opioid side effects. Anest Analg 2004; 98: 116-122.
2. Gelot A, Fioramonti J, Zaja̧c JM, Bueno L. Central effects of neuropeptide FF on intestinal motility in naive and morphine-dependent rats. Neuropeptides 1995; 29: 245-250.
3. Stewart JJ, Weisbrodt NW, Burks TF. Centrally mediated intestinal stimulation by morphine. J Pharmacol Exp Ther 1977; 202: 174-181.
4. Stewart JJ, Weisbrodt NW, Burks TF. Central and peripheral actions of morphine on intestinal transit. J Pharmacol Exp Ther 1978; 205: 547-555.
5. Kurz A, Sessler DI. Opioid induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 2003; 63: 649-671.
6. Johnson S, Fleming W. Mechanisms of cellular adaptive sensitivity changes: applications to opioid tolerance and dependence. Pharmacol Rev 1989; 41: 435-488.
7. Hanani M, Freund HR. Interstitial cells of Cajal - their role in pacing and signal transmission in the digestive system. Acta Physiol Scand 2000; 170: 177-190.
8. Maeda H, Yamagata A, Nishikawa S. Requirement of c-kit for development of interstitial pacemaker system. Development 1992; 116: 369-375.
9. Williams CL, Bihm CC, Rosenfeld GC, Burks TF. Morphine tolerance and dependence in the rat intestine in vivo. J Pharmacol Exp Ther 1996; 280: 656-663.
10. Fenik V, Fenik P, Kubin L. Simple cuff electrode for nerve recording and stimulation in acute experiments on small animals. J Neurosci Meth 2001; 106: 147-151.
11. Shook JE, Pelton JT, Lemcke PK, Porreca F, Hruby VJ, Burks TF. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptors related functions. J Pharmacol Exp Ther 1987; 242: 1-7.
12. Burks TF, Long JP. Responses of isolated dog small intestine to analgesic agents. J Pharmacol Exp Ther 1967; 158: 264-271.
13. Parolarlo D, Sala M, Gori E. Effect of intracerebroventricular administration of morphine upon intestinal motility in rat and its antagonism with naloxone. Eur J Pharmacol 1977; 46: 329-338.
14. Schwartz GJ. The role of gastrointestinal vagal afferents in the control of food intake: current prospects. Nutrition 2000; 16: 866-873.
15. Schwartz GJ, Moran TH. Duodenal nutrient exposure elicits nutrient-specific gut motility and vagal afferent signals in rat. Am J Physiol 1998; 274 (5 Pt. 2): 1236-1242.
16. Weisbrodt NW, Thor PJ, Copeland EM, Burks TF. Tolerance to the effects of morphine on intestinal motility of unanesthetized dogs. J Pharmacol Exp Ther 1980; 215: 515-521.
17. Shook JE, Pelton JT, Wire WS, Hirning LD, Hruby VJ, Burks TF. Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro. J Pharmacol Exp Ther 1986; 240: 772-777.
18. Blackshaw LA. Gastro-oesophageal afferent and serotonergic inputs to vagal afferent neurones. J Auton Nerv Syst 1994; 49: 93-103.
19. Królczyk G, Zurowski D, Sobocki J, Laskiewicz J, Thor PJ. Encoding meal in integrated vagal afferent discharge. J Physiol Pharmacol 2004; 55: 99-106.
20. Ozaki N, Sengupta JN, Gebhart GF. Differential effects of mu-, delta- and kappa-opioid receptor agonists on mechanosensitive gastric vagal afferent fibers in the rat. J Neurophysiol 2000; 83: 2209-2216.
21. Kaczynska K, Szereda-Przestaszewska M. Involvement of vagal opioid receptors in respiratory effects of morphine in anaesthetized rats. J Physiol Pharmacol 2005; 56: 195-203.
22. Ward SM, Burns AJ, Torihashi S, Sanders KM. Mutation of the proto-oncogene c-kit blocks development of interstitial cells and intestinal electrical rhythmicity in steel mutants. J Physiol (Lond) 1994; 480: 91-97.